UZH-Logo

Maintenance Infos

Browse by Communities & Collections - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items at this level: 355.

2017

Noske, Aurelia; Brandt, Simone; Valtcheva, Nadejda; Wagner, Ulrich; Zhong, Qing; Bellini, Elisa; Fink, Daniel; Obermann, Ellen C; Moch, Holger; Wild, Peter J (2017). Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer. OncoTarget, 8(9):14794-14805.

Wilkerson, Paul M; Dedes, Konstantin J; Samartzis, Eleftherios Pierre; Dedes, Ioannis; Lambros, Maryou B; Natrajan, Rachael; Gauthier, Arnaud; Piscuoglio, Salvatore; Töpfer, Chantal; Vukovic, Vesna; Daley, Frances; Weigelt, Britta; Reis-Filho, Jorge S (2017). Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer. OncoTarget, 8(4):6057-6066.

Schumpf, Lea F; Theill, Nathan; Scheiner, David A; Fink, Daniel; Riese, Florian; Betschart, Cornelia (2017). Urinary incontinence and its association with functional physical and cognitive health among female nursing home residents in Switzerland. BMC Geriatrics, 17(1):17.

Brandt, Simone; Samartzis, Eleftherios P; Zimmermann, Anne-Kathrin; Fink, Daniel; Moch, Holger; Noske, Aurelia; Dedes, Konstantin J. (2017). Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer. BMC Cancer, 17:44.

Betschart, Cornelia; Cervigni, Mauro; Contreras Ortiz, Oscar; Doumouchtsis, Stergios K; Koyama, Masayasu; Medina, Carlos; Haddad, Jorge Milhem; la Torre, Filippo; Zanni, Giuliano (2017). Management of apical compartment prolapse (uterine and vault prolapse): A FIGO Working Group report. Neurourology and Urodynamics, 36(2):507-513.

Schraag, Sabrina M; Caduff, Rosmarie; Dedes, Konstantin J; Fink, Daniel; Schmidt, Ana-Maria (2017). Uterine tumors resembling ovarian sex cord tumors: treatment, recurrence, pregnancy and brief review. Gynecologic Oncology Reports, 19:53-56.

2016

Matter-Walstra, Klazien; Schwenkglenks, Matthias; Aebi, Stefan; Dedes, Konstantin; Diebold, Joachim; Pietrini, Mario; Klingbiel, Dirk; von Moos, Roger; Gautschi, Oliver; Swiss Group for Clinical Cancer Research (2016). A cost-effectiveness analysis of nivolumab versus docetaxel for advanced nonsquamous NSCLC including PD-L1 testing. Journal of Thoracic Oncology, 11(11):1846-1855.

Betschart, Cornelia; Ghisu, Gian-Piero; Fink, Daniel (2016). Normale und abnorme kolposkopische Befunde. Praxis, 105(23):1363-1369.

Luo, Jiajia; Betschart, Cornelia; Ashton-Miller, James A; DeLancey, John O L (2016). Author's reply to letter from Matthes and Zucca-Matthes on "Quantitative analyses of variability in normal vaginal shape and dimension on MR images". International Urogynecology Journal and Pelvic Floor Dysfunction, 27(10):1611.

Scheiner, David; Bracone, Gabriela; Imesch, Patrick; Fink, Daniel; Imthurn, Bruno (2016). Comparison of quartz vials with polypropylene vials for rapid cryopreservation of human ovarian tissue. Journal of Ovarian Research, 9(1):59.

Scheiner, David A; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2016). Blut im Urin, was nun? Abklärung der nicht-sichtbaren Hämaturie bei der Frau. Praxis, 105(19):1133-1141.

Matter-Walstra, Klazien; Ruhstaller, T; Klingbiel, D; Schwenkglenks, Matthias; Dedes, K J (2016). Palbociclib as a first-line treatment in oestrogen receptor-positive, HER2-negative, advanced breast cancer not cost-effective with current pricing: a health economic analysis of the Swiss Group for Clinical Cancer Research (SAKK). Breast Cancer Research and Treatment, 158(1):51-57.

Luo, Jiajia; Betschart, Cornelia; Ashton-Miller, James A; DeLancey, John O L (2016). Quantitative analyses of variability in normal vaginal shape and dimension on MR images. International Urogynecology Journal and Pelvic Floor Dysfunction, 27(7):1087-1095.

Badir, S; Mazza, E; Bajka, M (2016). Objective assessment of cervical stiffness after administration of misoprostol for intrauterine contraceptive insertion. Ultrasound international open, 2(2):E63-E67.

Schmidt, Ana-Maria; Imesch, Patrick; Fink, Daniel; Egger, Herwig (2016). Pelvic exenterations for advanced and recurrent endometrial cancer: clinical outcomes of 40 patients. International Journal of Gynecological Cancer, 26(4):716-721.

Imesch, Patrick; Fink, Daniel (2016). Endometriosis Update 2016. Praxis, 105(5):253-257.

Pestalozzi, B; Fink, D (2016). Aszites. In: Kreuzer, Karl-Anton; Beyer, Jörg. Hämatologie und Onkologie : fallorientierte Darstellung - rationale Diagnostik und Therapie. Stuttgart: George Thieme Verlag, 88-89.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2016). Botox für die Blase. Leading Opinions - Gynäkologie & Geburtshilfe:25-29.

Baege, Astrid; Ghisu, Gian-Piero; Betschart, Cornelia; Fink, Daniel (2016). Die HPV-Impfung und -Typisierung in der Primär- und Sekundärprävention: Stellenwert in der Praxis. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 2016(4):20-24.

Fink, Daniel (2016). Editorial: Die Dysplasie-Sprechstunde. Gynäkologie, 4:1.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2016). Erythrozyten im Harn. Internistische Praxis:673-680.

Guaita, Alessandra. Fallkontrollstudie zur Steroidrezeptor-Expression in der vorderen Vaginalwand bei Frauen mit Zystozele und gesunden Kontrollen mittels Lasercapture Microdissection, Präamplifikation und quantitativer PCR. 2016, University of Zurich, Faculty of Medicine.

Imesch, Patrick. Histone modifications as a therapeutic apporach in endometriosis. 2016, University of Zurich, Faculty of Medicine.

Leo, C; Fink, D (2016). Knoten in der Brust. In: Kreuzer, Karl-Anton; Beyer, Jörg. Hämatologie und Onkologie : fallorientierte Darstellung - rationale Diagnostik und Therapie. Stuttgart: George Thieme Verlag, 86-88.

Rüttimann, Mirella. Korrelation von externer Kürettagehistologie, Schnellschnitt und definitiver Histologie bei am USZ operierten Endometriumkarzinom-Patientinnen. 2016, University of Zurich, Faculty of Medicine.

Dedes, Konstantin J; Fink, Daniel (2016). Mammakarzinom in der Schwangerschaft. info@gynäkologie, 6:18-21.

Perucchini, Daniele; Scheiner, David A; Fink, Daniel; Betschart, Cornelia (2016). Management der Mischinkontinenz. Schritt für Schritt zum Erfolg – Diagnostik, Therapie, Beratung. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 3:15-20.

Ghisu, Gian-Piero; Fink, Daniel (2016). Medikamentös oder chirurgisch? State of the Art der Abortbehandlung in der Frühschwangerschaft. info@gynäkologie, 2:12-14.

Imesch, Patrick; Fink, Daniel (2016). Nachsorge in der gynäkologischen Onkologie. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 5:6-9.

Dedes, K; Fink, D (2016). Neoplasien der weiblichen Geschlechtsorgane. Vulvakarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 399-400.

Imesch, P; Fink, D (2016). Neoplasien der weiblichen Geschlechtsorgane: Endometriumkarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 390-394.

Pestalozzi, Bernhard; Leo, Cornelia; Fink, Daniel (2016). Neoplasien der weiblichen Geschlechtsorgane: Mammakarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 373-385.

Dedes, K; Pestalozzi, B; Fink, D (2016). Neoplasien der weiblichen Geschlechtsorgane: Ovarial- und Tubenkarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 385-390.

Imesch, P; Fink, D (2016). Neoplasien der weiblichen Geschlechtsorgane: Zervixkarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 395-399.

Betschart, Cornelia; Ghisu, Gian-Piero; Baege, Astrid; Fink, Daniel (2016). Normale und abnormale kolposkopische Befunde: Klassifikation und Bedeutung: Welche Befunde sind „gefährlich“? Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 2016(4):6-13.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2016). Rezidivierende Harnwegsinfekte : Komplikationen, Therapieoptionen, Prävention. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 3:6-14.

Jasrotia, Arti. Role of NBS1 in DNA Double-Strand Break Response. 2016, University of Zurich, Faculty of Science.

Harter, P; du Bois, A; Mahner, S; Pfisterer, J; Ortmann, O; Marth, C; Fink, D; Hilpert, F; Wagner, U; Sehouli, J (2016). Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer. Geburtshilfe und Frauenheilkunde, 76(2):147-149.

Samartzis, E; Imesch, P; Twiehaus, A; Dubey, R K; Leeners, Brigitte (2016). The estrogen metabolites 2-methoxyestradiol and 2-hydroxyestradiol inhibit endometriotic cell proliferation in estrogen receptor independent manner. Gynecological Endocrinology, 32(7):529-533.

Ghisu, Gian-Piero; Baege, Astrid; Betschart, Cornelia; Fink, Daniel (2016). Therapie bei dysplastischen Veränderungen in der Gynäkologie. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 4:14-19.

Betschart, Cornelia; Perucchini, Daniele; Fink, Daniel; Scheiner, David (2016). Urininkontinenz und Sexualität. Hausarzt Praxis:2-4.

Ghisu, Gian-Piero; Fink, Daniel (2016). Verlauf der HPV-Infektion und Einteilung kolposkopischer Befunde. Gynaekologische Praxis, 41(2):187-199.

2015

Del Prete, Valerio; Chaloupka, Karla; Holzmann, David; Fink, Daniel; Levesque, Mitchell; Dummer, Reinhard; Goldinger, Simone M (2015). Noncutaneous melanomas: a single-center analysis. Dermatology, 232(1):22-29.

Larsen, Dorthe Helena; Stucki, Manuel (2015). Nucleolar responses to DNA double-strand breaks. Nucleic Acids Research, 44(2):538-544.

Henry, Claire; Llamosas, Estelle; Knipprath-Meszaros, Alexandra; Schoetzau, Andreas; Obermann, Ellen; Fuenfschilling, Maya; Caduff, Rosemarie; Fink, Daniel; Hacker, Neville; Ward, Robyn; Heinzelmann-Schwarz, Viola; Ford, Caroline (2015). Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. OncoTarget, 6(37):40310-40326.

Vaso, Martin; Betschart, Cornelia; Egger, Herwig; Fink, Daniel; Schmidt, Ana-Maria (2015). Surgical technique of a recurrent post-radiation vesicovaginal fistula with a small intestine graft. Archives of Gynecology and Obstetrics, 292(3):485-488.

Scheiner, David A; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2015). Interstitial cystitis/bladder pain syndrome (IC/BPS). Praxis, 104(17):909-918.

Maurer, M M; Badir, S; Pensalfini, M; Bajka, M; Abitabile, P; Zimmermann, R; Mazza, E (2015). Challenging the in-vivo assessment of biomechanical properties of the uterine cervix: A critical analysis of ultrasound based quasi-static procedures. Journal of Biomechanics, 48(9):1541-1548.

Myers, Kristin M; Feltovich, Helen; Mazza, Edoardo; Vink, Joy; Bajka, Michael; Wapner, Ronald J; Hall, Timothy J; House, Michael (2015). The mechanical role of the cervix in pregnancy. Journal of Biomechanics, 48(9):1511-1523.

Ghisu, Gian-Piero; Fink, Daniel (2015). Burning vulva: significance of surgery in inflammatory and precancerous vulvar pathologies. Praxis, 104(13):689-693.

Bajka, M; Badir, S (2015). Fundus thickness assessment by 3D transvaginal ultrasound allows metrics-based diagnosis and treatment of congenital uterine anomalies. Ultraschall in der Medizin, 38(02):183-189.

Birindelli, Esther; Fink, Daniel (2015). Abnormal Early Pregnancy: What Matters for Practice. Praxis, 104(12):617-621.

Nikolopoulos, Kostis I; Betschart, Cornelia; Doumouchtsis, Stergios K (2015). The surgical management of recurrent stress urinary incontinence: a systematic review. Acta Obstetricia et Gynecologica Scandinavica, 94(6):568-576.

Stucki, Manuel (2015). TORC2 inhibition may boost DNA-damaging chemotherapy. OncoTarget, 6(2):586-587.

Fürer, K; et al; von Mandach, U (2015). Inhibition of porcine detrusor contractility by the flavonoid fraction of Bryophyllum pinnatum - a potential phytotherapeutic drug for the treatment of the overactive bladder syndrome. Phytomedicine, 22(1):158-164.

Hempen, Aline; Samartzis, Eleftherios P; Kamarachev, Jivko; Fink, Daniel; Dedes, Konstantin J (2015). Acrokeratosis paraneoplastica in serous ovarian carcinoma: case report. BMC Cancer, 15(507):online.

Imesch, Patrick; Fink, Daniel (2015). Aktuelle Diagnostik und operative Therapie der Endometriose in der Praxis. info@gynäkologie, 2015(3):18-20.

Kim, Jinyong; Betschart, Cornelia; Ramanah, Rajeev; Ashton-Miller, James A; DeLancey, John O L (2015). Anatomy of the pubovisceral muscle origin: Macroscopic and microscopic findings within the injury zone. Neurourology and Urodynamics, 34(8):774-780.

Agca, Cavit; Boldt, Karsten; Gubler, Andrea; Meneau, Isabelle; Corpet, Armelle; Samardzija, Marijana; Stucki, Manuel; Ueffing, Marius; Grimm, Christian (2015). Expression of leukemia inhibitory factor in Müller glia cells is regulated by a redox-dependent mRNA stability mechanism. BMC Biology, 13(1):30.

Sikora, Michal; Scheiner, David; Betschart, Cornelia; Perucchini, Daniele; Mateos, José María; di Natale, Anthony; Fink, Daniel; Maake, Caroline (2015). Label-free, three-dimensional multiphoton microscopy of the connective tissue in the anterior vaginal wall. International Urogynecology Journal and Pelvic Floor Dysfunction, 26(5):685-691.

Wyss, Paloma Dolores. Papillary Lesions of the Breast: Outcomes of 156 Patients Managed without Excisional Biopsy. 2015, University of Zurich, Faculty of Medicine.

Ihnenfeld Arciénega, Isabel; Imesch, Patrick; Fink, Daniel; Dedes, Konstantin J (2015). Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature. Targeted oncology, 10(2):297-301.

Ture, M; Barth, J; Angst, F; Aeschlimann, A; Schnyder, U; Zerkiebel, N; Perseus, J; Renner, C; Imesch, P; Fuchs, B; Huber, G F; Walt, H; Martin-Soelch, C; Jenewein, J (2015). Use of inpatient rehabilitation for cancer patients in Switzerland: Who undergoes cancer rehabilitation? Swiss Medical Weekly, 145:w14214.

2014

Noske, Aurelia; Henricksen, Leigh A; LaFleur, Bonnie; Zimmermann, Anne-Katrin; Tubbs, Alisa; Singh, Shalini; Storz, Martina; Fink, Daniel; Moch, Holger (2014). Characterization of the 19q12 amplification including CCNE1 and URI in different epithelial ovarian cancer subtypes. Experimental and Molecular Pathology, 98(1):47-54.

Corpet, Armelle; Stucki, Manuel (2014). Chromatin maintenance and dynamics in senescence: a spotlight on SAHF formation and the epigenome of senescent cells. Chromosoma, 123(5):423-436.

Betschart, Cornelia; Kim, Jinyong; Miller, Janis M; Ashton-Miller, James A; DeLancey, John O L (2014). Comparison of muscle fiber directions between different levator ani muscle subdivisions: in vivo MRI measurements in women. International Urogynecology Journal and Pelvic Floor Dysfunction, 25(9):1263-1268.

Larsen, Dorthe H; Hari, Flurina; Clapperton, Julie A; Gwerder, Myriam; Gutsche, Katrin; Altmeyer, Matthias; Jungmichel, Stephanie; Toledo, Luis I; Fink, Daniel; Rask, Maj-Britt; Grøfte, Merete; Lukas, Claudia; Nielsen, Michael L; Smerdon, Stephen J; Lukas, Jiri; Stucki, Manuel (2014). The NBS1-Treacle complex controls ribosomal RNA transcription in response to DNA damage. Nature Cell Biology, 16(8):792-803.

Samartzis, Eleftherios P; Gutsche, Katrin; Dedes, Konstantin J; Fink, Daniel; Stucki, Manuel; Imesch, Patrick (2014). Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition. OncoTarget, 5(14):5295-5303.

Basler, Michelle; Jetter, Alexander; Fink, Daniel; Seifert, Burkhardt; Kullak-Ublick, Gerd A; Trojan, Andreas (2014). Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature. Breast Care, 9(3):182-187.

Ikenberg, Kristian; Valtcheva, Nadejda; Brandt, Simone; Zhong, Qing; Wong, Christine E; Noske, Aurelia; Rechsteiner, Markus; Rueschoff, Jan H; Caduff, Rosmarie; Dellas, Athanassios; Obermann, Ellen; Fink, Daniel; Fuchs, Thomas; Krek, Wilhelm; Moch, Holger; Frew, Ian J; Wild, Peter J (2014). KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. Journal of Pathology, 234(2):239-252.

Natrajan, R; Wilkerson, P M; Marchiò, C; Piscuoglio, Salvatore; Lambros, M B; Samartzis, Eleftherios P; Dedes, Konstantin J (2014). Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast. Journal of Pathology, 232(5):553-565.

Mazza, Edoardo; Parra-Saavedra, Miguel; Bajka, Michael; Gratacos, Eduard; Nicolaides, Kypros; Deprest, Jan (2014). In vivo assessment of the biomechanical properties of the uterine cervix in pregnancy. Prenatal Diagnosis, 34(1):33-41.

Betschart, Cornelia; Rizk, Diaa E E (2014). Climbing a long hill: pelvic floor surgery and the need for geriatric urogynecology. International urogynecology journal and pelvic floor dysfunction, 25(3):297-298.

Strutas, Deivis; Betschart, Cornelia; Fink, Daniel (2014). Das Vestibulitissyndrom. Gynäkologie, 4:25-19.

Corpet, Armelle; Olbrich, Teresa; Gwerder, Myriam; Fink, Daniel; Stucki, Manuel (2014). Dynamics of histone H3.3 deposition in proliferating and senescent cells reveals a DAXX-dependent targeting to PML-NBs important for pericentromeric heterochromatin organization. Cell Cycle, 13(2):0-18.

Koppensteiner, Romana; Samartzis, Eleftherios P; Noske, Aurelia; von Teichman, Adriana; Dedes, Ioannis; Gwerder, Myriam; Imesch, Patrick; Ikenberg, Kristian; Moch, Holger; Fink, Daniel; Stucki, Manuel; Dedes, Konstantin J (2014). Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro. PLoS ONE, 9(6):e100041.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2014). Erythrozyten im Harn. Wie ist das weitere Vorgehen? Gynaekologische Praxis, 38(2):271-279.

Baege, Astrid; Ghisu, Gian-Piero; Fink, Daniel (2014). Follow-up nach Therapie einer CIN, einer VIN und einer VAIN. Gynäkologie, 4:20-24.

Ghisu, Gian-Piero; Baege, Astrid; Fink, Daniel (2014). HPV-assoziierte Genitalerkrankungen. Gynäkologie, 4:14-19.

Schnabel, J; Heuer, H; Dedes, K; Fink, D (2014). Hochrisikokonstellation für Brustkrebs. Schweizer Zeitschrift für Onkologie, 3:28-32.

Graf, Dimitri. Interaktive Konzepte im E-Learning der Frauenheilkunde und Neonatologie. 2014, University of Zurich, Faculty of Medicine.

Imesch, Patrick; Fehr, Mathias; Fink, Daniel (2014). Karzinosarkome des Uterus (maligne Müller-Mischtumoren des Uterus, maligne mesodermale Mischtumoren, maligne gemischte mesenchymale Tumoren). In: Petru, Edgar; Jonat, Walter; Fink, Daniel; Köchli, Ossi R. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Verlag, 57-62.

Imesch, Patrick; Fehr, Mathias; Fink, Daniel (2014). Maligne epitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkomes). In: Petru, Edgar; Jonat, Walter; Fink, Daniel; Köchli, Ossi. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Verlag, 37-56.

Imesch, Patrick; Fehr, Mathias; Fink, Daniel (2014). Maligne nichtepitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkomes). In: Petru, Edgar; Jonat, Walter; Fink, Daniel; Köchli, Ossi R. Praxisbuch Gynäkologische Onkologie. Heildelberg: Springer Verlag, 65-70.

Buehler, Michelle. Meta-analysis of microarray data identifies GAS6 expression as an independent predictor of poor survival in ovarian cancer. 2014, University of Zurich, Faculty of Medicine.

Lohri, Corinne; Hutzli Schaltegger, Claudia S; van den Broek, Maries; Wenger, Roland H; Ruegg, Curzio; Fink, Daniel; Fehr, Mathias K; Knuth, Alexander; Zweifel, Martin (2014). Neutrophil expression of ICAM1, CXCR1, and VEGFR1 in patients with breast cancer before and after adjuvant chemotherapy. Anticancer Research, 34:4693-4700.

Fink, Daniel (2014). News from the San Antonio Breast Cancer Symposium 2013. Breast Care, 9(1):66-68.

Overactive Bladder: Fragen und Antworten. Edited by: Perucchini, Daniele (2014). Bremen: UNI-MED.

Fink, Daniel (2014). Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag.

Wiederer, Julia; Pazahr, Shila; Leo, Cornelia; Nanz, Daniel; Boss, Andreas (2014). Quantitative breast MRI: 2D histogram analysis of diffusion tensor parameters in normal tissue. Magma, 27(2):185-193.

Samartzis, Eleftherios P; Noske, Aurelia; Meisel, Alexander; Varga, Zsuzsanna; Fink, Daniel; Imesch, Patrick (2014). The G protein-coupled estrogen receptor (GPER) is expressed in two different subcellular localizations reflecting distinct tumor properties in breast cancer. PLoS ONE, 9(1):e83296.

Luo, Jiajia; Betschart, Cornelia; Chen, Luyun; Ashton-Miller, James A; Delancey, John O L (2014). Using stress MRI to analyze the 3D changes in apical ligament geometry from rest to maximal Valsalva: a pilot study. International Urogynecology Journal and Pelvic Floor Dysfunction, 25(2):197-203.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2014). Vom Fettgift zum modernen Therapeutikum – Botulinumneurotoxine. info@gynäkologie, 5:20-22.

Betschart, Cornelia; Strutas, Deivis; Fink, Daniel (2014). Vulvadermatosen. Gynäkologie, 4:6-12.

2013

Samartzis, Eleftherios P; Noske, Aurelia; Dedes, Konstantin J; Fink, Daniel; Imesch, Patrick (2013). ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas. International Journal of Molecular Sciences, 14(9):18824-18849.

Ghisu, Gian-Piero; Fink, Daniel (2013). Frühaborte und Abruptiones. Operative und medikamentöse Therapie. Gynäkologie, (1):9-13.

Imesch, Patrick; Samartzis, Eleftherios P; Dedes, Konstantin J; Fink, Daniel; Fedier, André (2013). Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells. Fertility and Sterility, 100(3):770-776.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2013). Botox in der Schwangerschaft und der Stillzeit. Hebamme.ch = Sage-femme.ch = Levatrice.ch = Spendrera.ch, (6):14-16.

Betschart, Cornelia; Perucchini, Daniele; Fink, Daniel; Scheiner, David (2013). Deszensuschirurgie. Neue und bewährte Techniken. Gynäkologie, (5):6-11.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2013). Die Belastungsinkontinenz. Diagnostik und Therapie. Gynäkologie, (5):12-17.

Betschart, Cornelia; Perucchini, Daniele; Fink, Daniel; Scheiner, David (2013). Die Bildgebung des Beckenbodens. Ultraschall und MRI. Gynäkologie, (5):23-26.

Perucchini, Daniele; Betschart, Cornelia; Scheiner, David; Fink, Daniel (2013). Die überaktive Blase. Differenzialdiagnostik und therapeutisches Management. Gynäkologie, (5):18-22.

Imesch, Patrick; Fink, Daniel (2013). Das Endometriumkarzinom: Diagnostik und Therapie. Schweizer Zeitschrift für Onkologie, (4):2-6.

Hauser, Nik. Development and Clinical Evaluation of New Approaches in Breast Cancer Diagnosis: Differential Phase Contrast Mammography. 2013, University of Zurich, Faculty of Medicine.

Scheiner, David; Betschart, Cornelia; Perucchini, Daniele (2013). Aktueller Stellenwert der Netzchirurgie. Fortbildung Genitaldeszensus. info@gynäkologie, 1:6-8.

Badir, Sabrina; Bajka, Michael; Mazza, Edoardo (2013). A novel procedure for the mechanical characterization of the uterine cervix during pregnancy. Journal of the Mechanical Behavior of Biomedical Materials, 27:143-153.

Senn, Beate; Eicher, Manuela; Mueller, Michael D; Hornung, René; Fink, Daniel; Baessler, Kaven; Hampl, Monika; Denhaerynck, Kris; Spirig, Rebecca; Engberg, Sandra (2013). A patient-reported outcome measure to identify occurrence and distress of post-surgery symptoms of WOMen with vulvAr Neoplasia (WOMAN-PRO) - a cross sectional study. Gynecologic Oncology, 129(1):234-240.

Bajka, Michael (2013). Antikonzeption – Wo der Ultraschall massgeblich unterstützt. Praxis, 102(12):713-719.

Charpidou, Theodosia; Lang, Franziska; Langenegger, Thomas; Dedes, Konstantin J; Honegger, Christoph (2013). Bilateral transient osteoporosis of the knee during pregnancy. Archives of Gynecology and Obstetrics, 287(6):1259-1261.

Tausch, C; Baege, A; Dietrich, D; Vergin, I; Heuer, H; Haldemann Heusler, R; Rageth, C (2013). Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? European Journal of Surgical Oncology, 39(8):880-886.

Imesch, Patrick; Scheiner, David; Szabo, Emese; Fink, Daniel; Fedier, André (2013). Conjugates of cytochrome c and antennapedia peptide activate apoptosis and inhibit proliferation of HeLa cancer cells. Experimental and Therapeutic Medicine, 6(3):786-790.

Imesch, Patrick; Scheiner, David; Xie, Min; Fink, Daniel; Macas, Erwin; Dubey, Raghvendra; Imthurn, Bruno (2013). Developmental potential of human oocytes matured in vitro followed by vitrification and activation. Journal of Ovarian Research, 6:30.

Fehr, Mathias K; Baumann, Marc; Mueller, Michael; Fink, Daniel; Heinzl, Siegfried; Imesch, Patrick; Dedes, Konstantin (2013). Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia. Journal of Gynecologic Oncology, 24(3):236-241.

Kohl Schwartz, A S; Leo, C; Rufibach, Kaspar; Varga, Z; Fink, D; Gabriel, N (2013). Does increased tumor burden of sentinel nodes in breast cancer affect detection procedure? European Journal of Surgical Oncology, 39(3):266-272.

Zimmermann, Anne-Katrin; Imig, Jochen; Klar, Agnes; Renner, Christoph; Korol, Dimitri; Fink, Daniel; Stadlmann, Sylvia; Singer, Gad; Knuth, Alexander; Moch, Holger; Caduff, Rosmarie (2013). Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomas. Virchows Archiv, 462(5):565-574.

Samartzis, Nicolas. Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: A tissue microarray study. 2013, University of Zurich, Faculty of Medicine.

Graf, Nina. Frequency and risk factors of lower limb lymphedema following lymphadenecomy in patients with gynecological malignancies. 2013, University of Zurich, Faculty of Medicine.

Graf, N; Rufibach, Kaspar; Schmidt, A M; Fehr, M; Fink, D; Baege, A C (2013). Frequency and risk factors of lower limb lymphedema following lymphadenectomy in patients with gynecological malignancies. European Journal of Gynaecological Oncology, 34(1):23-27.

Nygaard, Christiana Campani; Betschart, Cornelia; Hafez, Ahmed A; Lewis, Erica; Chasiotis, Ilias; Doumouchtsis, Stergios K (2013). Impact of menopausal status on the outcome of pelvic floor physiotherapy in women with urinary incontinence. International Urogynecology Journal and Pelvic Floor Dysfunction, 24(12):2071-2076.

Leimbacher, Barbara Tamara. Inpatient and outpatient loop electrosurgery excision procedure for cervical intraepithelial neoplasia: a retrospective analysis. 2013, University of Zurich, Faculty of Medicine.

Scheiner, David; Maggi, N; Perucchini, Daniele; Betschart, Cornelia (2013). Keimbefall bei Frauen mit und ohne OAB. Prävalenz von Urea- und Mycoplasmen, Gonokokken und Chlamydien im Urethralabstrich. Urologische Nachrichten, 3:9.

Buehler, Michelle; Tse, Brian; Leboucq, Alix; Jacob, Francis; Caduff, Rosmarie; Fink, Daniel; Goldstein, Darlene R; Heinzelmann-Schwarz, Viola (2013). Meta-Analysis of Microarray Data Identifies GAS6 Expression as an Independent Predictor of Poor Survival in Ovarian Cancer. BioMed Research International, 2013:238284.

Betschart, C; Chen, L; Ashton-Miller, J A; Delancey, J O L (2013). On pelvic reference lines and the MR evaluation of genital prolapse: a proposal for standardization using the Pelvic Inclination Correction System. International urogynecology journal and pelvic floor dysfunction, 24(9):1421-1428.

Betschart, Cornelia; Mol, Suzanne E; Lütolf-Keller, Béatrice; Fink, Daniel; Perucchini, Daniele; Scheiner, David (2013). Pelvic floor muscle training for urinary incontinence: a comparison of outcomes in premenopausal versus postmenopausal women. Female Pelvic Medicine and Reconstructive Surgery, 19(4):219-224.

Betschart, Cornelia; von Mandach, Ursula; Seifert, Burkhardt; Scheiner, David; Perucchini, Daniele; Fink, Daniel; Geissbühler, Verena (2013). Randomized, double-blind placebo-controlled trial with Bryophyllum pinnatum versus placebo for the treatment of overactive bladder in postmenopausal women. Phytomedicine, 20(3-4):351-358.

Abascal, Federico; Corpet, Armelle; Gurard-Levin, Zachary A; Juan, David; Ochsenbein, Françoise; Rico, Daniel; Valencia, Alfonso; Almouzni, Geneviève (2013). Subfunctionalization via adaptive evolution influenced by genomic context: the case of histone chaperones ASF1a and ASF1b. Molecular Biology and Evolution, 30(8):1853-1866.

Rechsteiner, Markus; Zimmermann, Anne-Katrin; Wild, Peter J; Caduff, Rosmarie; von Teichman, Adriana; Fink, Daniel; Moch, Holger; Noske, Aurelia (2013). TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type. Experimental and Molecular Pathology, 95(2):235-241.

Samartzis, Eleftherios P; Noske, Aurelia; Samartzis, Nicolas; Fink, Daniel; Imesch, Patrick (2013). The expression of histone deacetylase 1, but not other class I histone deacetylases, is significantly increased in Endometriosis. Reproductive Sciences, 20(12):1416-1422.

Teleki, Ivett; Krenacs, Tibor; Szasz, Marcell A; Kulka, Janina; Wichmann, Barna; Leo, Cornelia; Papassotiropoulos, Barbel; Riemenschnitter, Cosima; Moch, Holger; Varga, Zsuzsanna (2013). The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer. BMC Cancer, 13(1):50.

2012

Ackerknecht-Koch, Annemarie. Expression von Steroidhormon-Rezeptoren bei Frauen mit Zystozele. 2012, University of Zurich, Faculty of Medicine.

Ukegjini, Kristjan. Loss of Secreted Frizzled-Related Protein 4 Correlates with an Aggressive Phenotype and Predicts Poor Outcome in Ovarian Cancer Patients. 2012, University of Zurich, Faculty of Medicine.

Imesch, Patrick; Goerens, Anouk; Fink, Daniel; Fedier, André (2012). MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3'-deoxyadenosine) in vitro. Oncology Letters, 3(2):441-444.

Betschart, C; Perucchini, D; Scheiner, D (2012). Altersadaptierte Urogynäkologie: Krankheitsbilder, Evaluation und Management der Blase im Alter. Ars Medici, (III):23-26.

Fink, D (2012). Das Chamäleon unter den gynäkologischen Erkrankungen. Gynäkologie, (3):1.

Mueller, M; Eberhard, M; De Geyter, C; Häberlin, F; Hohl, M K; Imesch, P; Polli, C; Possover, M; Schiessl, K; Wenger, J M; Wunder, D (2012). Diagnostik und Therapie der Endometriose. Frauenheilkunde Aktuell, 21(2):28-34.

Empfehlungen zur Ultraschalldiagnostik in der Gynäkologie. Edited by: Bajka, M; Berclaz, G; Müller, R C; Schär, G; Tercanli, S (2012). Zürich: Schweizerischen Gesellschaft für Ultraschall in der Medizin Sektion Gynäkologie und Geburtshilfe (SGUMGG) .

Samartzis, Nicolas; Samartzis, Eleftherios P; Noske, Aurelia; Fedier, Andre; Dedes, Konstantin J; Caduff, Rosmarie; Fink, Daniel; Imesch, Patrick (2012). Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study. Reproductive Biology and Endocrinology, 10:30.

Imesch, P; Fink, D (2012). Fertilitätserhaltende Therapien bei Ovarial- und Borderline-Tumoren. Leading Opinions Hämatologie & Onkologie, (5):52-54.

Fink, D (2012). Gatekeeper Frauenarztpraxis. Gynäkologie, (5):1.

Scheiner, D; Perucchini, D; Fink, Daniel; Betschart, C (2012). Gynäkologie: Fälle aus der Harninkontinenz-Sprechstunde. Praxis, 101(9):585-592.

Panel, Pierre; Bajka, Michael; Le Tohic, Arnaud; Ghoneimi, Alaa El; Chis, Carmen; Cotin, Stéphane (2012). Hysteroscopic placement of tubal sterilization implants: virtual reality simulator training. Surgical Endoscopy, 26(7):1986-1996.

Schmidt, A-M; Imesch, P; Fink, Daniel; Egger, H (2012). Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Gynecologic oncology, 125(3):604-609.

Leimbacher, B; Samartzis, N; Imesch, P; Dedes, K J; Fink, D; Canonica, C (2012). Inpatient and outpatient loop electrosurgery excision procedure for cervical intraepithelial neoplasia: a retrospective analysis. Archives of Gynecology and Obstetrics, 285(5):1441-1445.

Samartzis, Eleftherios P; Samartzis, Nicolas; Noske, Aurelia; Fedier, André; Caduff, Rosmarie; Dedes, Konstantin J; Fink, Daniel; Imesch, Patrick (2012). Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation? Modern Pathology, 25(6):885-892.

Jacob, Francis; Ukegjini, Kristjan; Nixdorf, Sheri; Ford, Caroline E; Olivier, Jake; Caduff, Rosmarie; Scurry, James P; Guertler, Rea; Hornung, Daniela; Mueller, Renato; Fink, Daniel A; Hacker, Neville F; Heinzelmann-Schwarz, Viola A (2012). Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients. PLoS ONE, 7(2):e31885.

Hollenstein, M; Bajka, M; Röhrnbauer, B; Badir, S; Mazza, E (2012). Measuring the in vivo behavior of soft tissue and organs using the aspiration device. In: Payan, Y. Soft Tissue Biomechanical Modeling for Computer Assisted Surgery. Heidelberg: Springer, 201-228.

Imesch, P; Samartzis, E P; Fink, D (2012). Medikamentöse Therapie der Endometriose. Gynäkologie, (3):17-21.

Imesch, P; Samartzis, E P; Fink, D (2012). Medikamentöse Therapie der Endometriose. Ars Medici, (18):934-937.

Imesch, P; Fink, D (2012). Nachsorge in de gynäkologischen Onkologie. Gynäkologie, (5):6-9.

Betschart, C; Scheiner, D; Perucchini, D (2012). Nr. 1: Abklärung bei Harninkontinenz und Genitaldeszensus. Gynäkologie, (2):34-38.

Betschart, C; Scheiner, D; Perucchini, D (2012). Nr. 2: Die Behandlung bei Genitaldeszensus. Gynäkologie, (3):34-38.

Betschart, C; Scheiner, D; Perucchini, D (2012). Nr. 3: Die Behandlung bei Belastungsinkontinenz. Gynäkologie, (4):31-36.

Betschart, C; Scheiner, D; Perucchini, D (2012). Nr. 4: Die Behandlung bei überaktiver Blase. Gynäkologie, (5):21-24.

Church, D N; Koppensteiner, R; Yap, T; Fink, Daniel; Dedes, K J (2012). P13K-AKT-mTOR inhibitors for the systematic treatment of endometrial cancer. Expert Review of Obstetrics & Gynecology, 7(5):421-430.

Samartzis, E P; Imesch, P; Fink, D (2012). Pathogenese der Endometriose. Gynäkologie, (3):6-10.

Dedes, K J; Fink, Daniel; Steiner, R A (2012). Principes de la chimiothérapie. In: Hornung, R; Fink, Daniel. Traitement de deuxième intention du cancer du sein. Bremen: UNI-MED Verlag, 50-54.

Imesch, P; Samartzis, E P; Fink, D (2012). Prävalenz, Diagnostik und Therapie der Endometriose. info@gynäkologie, (3):19-21.

Jacob, F; Goldstein, D R; Bovin, N V; Pochechueva, T; Spengler, M; Caduff, R; Fink, D; Vuskovic, M I; Huflejt, M E; Heinzelmann-Schwarz, V (2012). Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. International Journal of Cancer, 130(1):138-146.

Fink, Daniel; Leo, C (2012). Synopsis des principales études concernant le traitement du cancer du sein au stade métastatique. In: Hornung, R; Fink, Daniel. Traitement de deuxième intention du cancer du sein. Bremen: UNI-MED Verlag, 72-82.

Chirgwin, J; Sun, Z; Smith, I; Price, K N; Thürlimann, B; Ejlertsen, B; Bonnefoi, H; Regan, M M; Goldhirsch, A; Coates, A S (2012). The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Breast Cancer Research and Treatment, 131(1):295-306.

Jungmichel, Stephanie; Clapperton, Julie A; Lloyd, Janette; Hari, Flurina J; Spycher, Christoph; Pavic, Lucijana; Li, Jiejin; Haire, Lesley F; Bonalli, Mario; Larsen, Dorthe H; Lukas, Claudia; Lukas, Jiri; MacMillan, Derek; Nielsen, Michael L; Stucki, Manuel; Smerdon, Stephen J (2012). The molecular basis of ATM-dependent dimerization of the Mdc1 DNA damage checkpoint mediator. Nucleic Acids Research, 40(9):3913-3928.

Schneider, Priska; von Orelli, Stephanie; Roos, Malgorzata; Leo, Cornelia; Fink, Daniel; Wyss, Pius (2012). The value of endocervical curettage after conization for cervical intraepithelial neoplasia. Annals of Diagnostic Pathology, 16(4):245-249.

Schneider, Priska. The value of endocervical curettage following conization for cervical intraepithelial neoplasia. 2012, University of Zurich, Faculty of Medicine.

Fink, D (2012). Therapie des Ovarialkarzinoms. Leading Opinions Medizin für die Frau, (3):31-32.

Traitement de deuxième intention du cancer du sein. Edited by: Hornung, R; Fink, Daniel (2012). Bremen : UNI-MED Verlag.

Scheiner, D A; Betschart, C; Wiederkehr, S; Seifert, Burkhardt; Fink, D; Perucchini, D (2012). Twelve months effect on voiding function of retropubic compared with outside-in and inside-out transobturator midurethral slings. International Urogynecology Journal, 23(2):197-206.

Widerkehr Sykora, Sandra Clelia. Vergleich der retropubischen (TVT) mit der transobturatorischen (outside - in T.O.T. oder inside - out TVT-O) Schlingentechnik in der chirurgischen Behandlung der weiblichen Belastungs- oder belastungsbetonten Mischinkontinenz. 2012, University of Zurich, Faculty of Medicine.

Imesch, P; Fink, D; Gabriel, N (2012). Was bringt ein Screening beim Ovarial- und Korpus-Ca? Leading Opinions Medizin für die Frau, (3):28-30.

Wild, Peter J; Ikenberg, Kristian; Fuchs, Thomas J; Rechsteiner, Markus; Georgiev, Strahil; Fankhauser, Niklaus; Noske, Aurelia; Roessle, Matthias; Caduff, Rosmarie; Dellas, Athanassios; Fink, Daniel; Moch, Holger; Krek, Wilhelm; Frew, Ian J (2012). p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans. EMBO Molecular Medicine, 4(8):808-824.

2011

Zweitlinientherapie des Mammakarzinoms. Edited by: Hornung, R; Fink, D (2011). Bremen, DE: UNI-MED Verlag.

Fink, D; Fehr, M K (2011). Maligne nichtepitheliale Tumoren des Ovars. In: Petru, E; Jonat, W; Fink, D; Köchli, O R. Praxisbuch gynäkologische Onkologie (3. Aufl.). Berlin, DE: Springer, 133-140.

Stevanovic, N. Roboterchirurgie in der Gynäkologie, erste Erfahrungen in der Pilot- und Routinephase an der Frauenklinik des Kantonsspitals Aarau. 2011, University of Zurich, Faculty of Medicine.

Fehr, M K; Fink, D (2011). Karzinosarkome des Uterus (maligne Müller-Mischtumoren des Uterus, maligne mesodermale Mischtumoren, maligne gemischte mesenchymale Tumoren). In: Petru, E; Jonat, W; Fink, D; Köchli, O R. Praxisbuch gynäkologische Onkologie (3. Aufl.). Berlin, DE: Springer, 57-62.

Fehr, M K; Fink, D (2011). Maligne epitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkoms). In: Petru, E; Jonat, W; Fink, D; Köchli, O R. Praxisbuch Gynäkologische Onkologie (3. Aufl.). Berlin, DE: Springer, 40-55.

Fehr, M K; Fink, D (2011). Maligne, nichtepitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkoms). In: Petru, E; Jonat, W; Fink, D; Köchli, O R. Praxisbuch gynäkologische Onkologie (3. Aufl.). Berlin, DE: Springer, 64-69.

Praxisbuch gynäkologische Onkologie (3. Aufl.). Edited by: Petru, E; Jonat, W; Fink, D; Köchli, O R (2011). Berlin, DE: Springer.

Hess-Arnold, E. Patientinnenzufriedenheit nach retropubischer und transobturatorischer Schlingenoperation : Langzeitergebnisse, erhoben mit dem Incontinence Outcome Questionnaire (IOQ). 2011, University of Zurich, Faculty of Medicine.

Zagoury Günzburger, J. Einfluss von Axilla-Ultraschall und Punktion der axillären Lymphknoten auf das chirurgische Vorgehen in der Axilla beim Mammakarzinom. 2011, University of Zurich, Faculty of Medicine.

Meier, Mara Isabella Eva. No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. 2011, University of Zurich, Faculty of Medicine.

Burger, I A; Scheiner, D A; Crook, D W; Treyer, V; Hany, T F; von Schulthess, G K (2011). FDG uptake in vaginal tampons is caused by urinary contamination and related to tampon position. European Journal of Nuclear Medicine and Molecular Imaging, 38(1):90-96.

Perren, T J; Swart, A M; Pfisterer, J; Ledermann, J A; Pujade-Lauraine, E; Kristensen, G; Carey, M S; Beale, P; Cervantes, A; Kurzeder, C; du Bois, A; Sehouli, J; Kimmig, R; Stähle, A; Collinson, F; Essapen, S; Gourley, C; Lortholary, A; Selle, F; Mirza, M R; Leminen, A; Plante, M; Stark, D; Qian, W; Parmar, M K B; Oza, A M (2011). A phase 3 trial of bevacizumab in ovarian cancer. New England Journal of Medicine, 365(26):2484-2496.

Noske, A; Zimmermann, A K; Caduff, R; Varga, Z; Fink, D; Moch, H; Kristiansen, G (2011). Alpha-methylacyl-CoA racemase (AMACR) expression in epithelial ovarian cancer. Virchows Archiv, 459(1):91-97.

Betschart, C; Perucchini, D; Scheiner, D (2011). Altersadaptierte Urogynäkologie: Krankheitsbilder, Evaluation und Management der Blase im Alter. Gynäkologie, (2):11-14.

Betschart, C; Perucchini, D; Scheiner, D (2011). Altersadaptierte Urogynäkologie: Krankheitsbilder, Evaluation und Management der Blase im Alter. Ars Medici, (15):619-623.

Regan, M M; Neven, P; Giobbie-Hurder, A; Goldhirsch, A; Ejlertsen, B; Mauriac, L; Forbes, J F; Smith, I; Láng, I; Wardley, A; Rabaglio, M; Price, K N; Gelber, R D; Coates, A S; Thürlimann, B (2011). Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. Lancet Oncology, 12(12):1101-1108.

Fink, D (2011). Beratung zur Prävention – stetiger Diskussionsstoff. Gynäkologie, (4):1.

Achtari, C; Fink, D; Günthert, A R; Huober, J; Pestalozzi, B; Petignat, P; von Moos, R; Sessa, C (2011). Bevacizumab in the primary treatment of epithelial ovarian cancer – some comments on the latest results. Schweizer Krebs-Bulletin = Bulletin Suisse du Cancer, 35(1):35-38.

von Mandach, U; Betschart, C (2011). Bryophyllum pinnatum in der Geburtshilfe und Gynäkologie. Wirksamkeit und Verträglichkeit. info@gynäkologie, (3):16-20.

Toller, I M; Neelsen, K J; Steger, M; Hartung, M L; Hottiger, M O; Stucki, M; Kalali, B; Gerhard, M; Sartori, A A; Lopes, M; Müller, A (2011). Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 108(36):14944-14949.

Pochechueva, T; Jacob, F; Goldstein, D R; Huflejt, M E; Chinarev, A; Caduff, R; Fink, D; Hacker, N; Bovin, N V; Heinzelmann-Schwarz, V (2011). Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies. Glycoconjugate Journal, 28(8-9):507-517.

Imesch, P; Hornung, R; Fink, D; Fedier, A (2011). Cordycepin (3'-Deoxyadenosine), an Inhibitor of mRNA Polyadenylation, Suppresses Proliferation and Activates Apoptosis in Human Epithelial Endometriotic Cells in vitro. Gynecologic and Obstetric Investigation, 72(1):43-49.

Heinzelmann-Schwarz, V (2011). Das epitheliale Ovarialkarzinom – ein Paradigmenwandel. Therapeutische Umschau, 68(10):565-572.

Schlatter, C (2011). Der aufsteigende Genitalinfekt: Aktuelle Diagnostik- und Therapiekonzepte. Gynäkologie, (4):20-23.

Dedes, K J; Natrajan, R; Lambros, M B; Geyer, F C; Lopez-Garcia, M A; Savage, K; Jones, R L; Reis-Filho, J S (2011). Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. European Journal of Cancer, 47(1):138-150.

Ibrahimi, B. Effect of the histone deacetylase inhibitor Romidepsin on proliferation and migration of human epithelial endometriotic cells and on expression of E-cadherin and matrix metalloproteinase-2. 2011, University of Zurich, Faculty of Medicine.

Dedes, K J; Wetterskog, D; Ashworth, A; Kaye, S B; Reis-Filho, J S (2011). Emerging therapeutic targets in endometrial cancer. Nature Reviews. Clinical Oncology, 8(5):261-271.

Imesch, P; Samartzis, E P; Fink, D (2011). Endometriose - eine epigenetische Erkrankung? Leading Opinions - Medizin für die Frau, 4(1):2-4.

Leo, C; Fink, D (2011). Epithelial-zu-mesenchymale Transition (EMT) - Neue molekulare Einsichten in die Tumorprogression. Geburtshilfe und Frauenheilkunde, 71(01):21-25.

Leo, C; Fink, D (2011). Erythropoietin in der onkologischen Therapie – was wissen wir über die Risiken? Praxis, 100(20):1239-46.

Samartzis, N; Imesch, P; Dedes, K J; Samartzis, E P; Fedier, A; Fink, D; Caduff, R; Fehr, M K (2011). Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: A tissue microarray study. BMC Cancer, 11:463.

Wilkerson, P M; Dedes, K J; Wetterskog, D; Mackay, A; Lambros, M B; Mansour, M; Frankum, J; Lord, C J; Natrajan, R; Ashworth, A; Reis-Filho, J S (2011). Functional characterization of EMSY gene amplification in human cancers. Journal of Pathology, 225(1):29-42.

Brough, R; Frankum, J R; Sims, D; Mackay, A; Mendes-Pereira, A M; Bajrami, I; Costa-Cabral, S; Rafiq, R; Ahmad, A S; Cerone, M A; Natrajan, R; Sharpe, R; Shiu, K K; Wetterskog, D; Dedes, K J; Lambros, M B; Rawjee, T; Linardopoulos, S; Reis-Filho, J S; Turner, N C; Lord, C J; Ashworth, A (2011). Functional viability profiles of breast cancer. Cancer Discovery, 1(3):260-273.

Betschart, C; Kerl, K; Fink, D (2011). Harninkontinenz macht nicht nur nass! Diagnose und Therapie lokaler Begleiterkrankungen der Harninkontinenz. Leading Opinions - Medizin für die Frau, 4:26-29.

Imesch, P; Samartzis, E P; Schneider, M; Fink, D; Fedier, A (2011). Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin. Fertility and Sterility, 95(5):1579-1583.

Regan, M M; Price, K N; Giobbie-Hurder, A; Thürlimann, B; Gelber, R D (2011). Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer. Breast Cancer Research, 13(3):209.

Fink, D; Hutzli Schaltegger, C (2011). Intraoperative Radiotherapie: Neue Therapieoption beim Mammakarzinom. Kongress Special, (5-6):9.

Gabriel, N; Fink, D (2011). Lifestyleänderungen nach Mammakarzinom. Empfohlene Massnahmen und Fragen in der Beratung. Gynäkologie, (4):6-9.

Imesch, P; Goehrens, A; Fink, D; Fedier, A (2011). MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3'-deoxyadenosine)in vitro. Oncology Letters, 3(2):441-444.

Fink, D (2011). Mamma-Screening: Ältere Studien sprechen dafür, neue warnen. Kongress Special, (3-4):9.

Hirsch, S; Szczerba, D; Lloyd, B; Bajka, M; Kuster, N; Székely, G (2011). Mechano-chemical simulation of solid tumor dynamics for therapy outcome predictions. International Journal for Multiscale Computational Engineering, 9(2):231-241.

Pochechueva, T; Chinarev, A; Spengler, M; Korchagina, E; Heinzelmann-Schwarz, V; Bovin, N; Rieben, R (2011). Multiplex suspension array for human anti-carbohydrate antibody profiling. The Analyst, 136(3):560-569.

Betschart, C (2011). Neue Therapieoptionen gegen verstärkte uterine Blutungen. Vorgehen bei Hypermenorrhoe. info@gynäkologie, (1):36-37.

Jacob, F; Meier, M; Caduff, R; Goldstein, D; Pochechueva, T; Hacker, N; Fink, D; Heinzelmann-Schwarz, V (2011). No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. Gynecologic Oncology, 121(3):487-491.

Dedes, K J; Fink, D (2011). Ovarial-, Zervix- und Vulvakarzinom: Neues zu gynäkologischen Tumoren. Hausarzt Praxis, 8(15):15-18.

Betschart, C; Scheiner, D; Hess, E; Seifert, Burkhardt; Fink, D; Perucchini, D (2011). Patient satisfaction after retropubic and transobturator slings: first assessment using the Incontinence Outcome Questionnaire (IOQ). International Urogynecology Journal, 22(7):805-812.

Kut, E; Candia, V; von Overbeck, J; Pok, J; Fink, D; Folkers, G (2011). Pleasure-related analgesia activates opioid-insensitive circuits. Journal of Neuroscience, 31(11):4148-53.

Leo, C; Fink, D (2011). Prävention und Screening beim Mammakarzinom. Pro und Kontra des Mammografiescreenings. Schweizer Zeitschrift für Onkologie, (3):6-9.

Betschart, C; Scheiner, D; Fink, D (2011). Reizblase bei der Frau: Neue Therapieansätze. Hausarzt Praxis, (8):30-32.

Papadatos-Pastos, D; Dedes, K J; de Bono, J S; Kaye, S B (2011). Revisiting the role of antiandrogen strategies in ovarian cancer. The Oncologist, 16(10):1413-1421.

Fink, D; Leo, C (2011). Synopsis grösserer Studien zur Therapie des metastasierten Mammakarzinoms. In: Hornung, R; Fink, D. Zweitlinientherapie des Mammakarzinoms. Bremen, DE: UNI-MED Verlag, 70-79.

Dedes, K J; Wilkerson, P M; Wetterskog, D; Weigelt, B; Ashworth, A; Reis-Filho, J S (2011). Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations. Cell Cycle, 10(8):1192-1199.

Dedes, K J; Fink, D; Steiner, R (2011). Systemische Tumorkontrolle: Chemotherapeutische Prinzipien. In: Hornung, R; Fink, D. Zweitlinientherapie des Mammakarzinoms. Bremen, DE: UNI-MED Verlag, 47-52.

Scheiner, D; Betschart, C; Fink, D; Perucchini, D (2011). TVT, TOT und TVT-O: Schweizer 1-Jahres-Resultate. Vergleich verschiedener Schlingen bei Inkontinenz. Leading Opinions - Medizin für die Frau, 4(3):26-29.

Schwager, K; Bootz, F; Imesch, P; Kaspar, M; Trachsel, E; Neri, D (2011). The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model. Human Reproduction, 26(9):2344-2352.

Forster, M D; Dedes, K J; Sandhu, S; Frentzas, S; Kristeleit, R; Ashworth, A; Poole, C J; Weigelt, B; Kaye, S B; Rhoda Molife, L (2011). Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nature Reviews. Clinical Oncology, 8(5):302-306.

Theurillat, J P; Metzler, S C; Henzi, N; Djouder, N; Helbling, M; Zimmermann, A K; Jacob, F; Soltermann, A; Caduff, R; Heinzelmann-Schwarz, V; Moch, H; Krek, W (2011). URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell, 19(3):317-332.

Imesch, P; Fink, D (2011). Zervixkarzinom. Therapeutische Umschau, 68(10):545-552.

Kunz, Corinna Daniela. Zervixkarzinom-Screening: Untersuchung zur Korrelation von Zytologie und Histologie an 173 Konisaten unter Berücksichtigung der Infektion mit humanpathogenen Papillomaviren. 2011, University of Zurich, Faculty of Medicine.

Bajka, M (2011). Zystischer Unterbauchtumor. Praxis, 100(25):1543-1548.

2010

Seiler, Rebekka C. Blutverlust und Therapie der hämorrhagisch-bedingten Hypovolämie bei gynäkologischen Genitalkarzinomen am UniversitätsSpital Zürich. 2010, University of Zurich, Faculty of Medicine.

Barchiesi, F; Lucchinetti, E; Zaugg, M; Ogunshola, O O; Wright, M; Meyer, Markus; Rosselli, M; Schaufelberger, S; Gillespie, D G; Jackson, E K; Dubey, R K (2010). Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection. Hypertension, 56(5):964-972.

Dacheva, T P. Prävalenz HPV bedingter anogenitaler Veränderungen bei lungentransplantierten Patientinnen. 2010, University of Zurich, Faculty of Medicine.

Leo, C. Hypoxie-vermittelte Mechanismen der Tumorprogression am Modell des Zervixkarzinoms. 2010, University of Zurich, Faculty of Medicine.

Gabriel, N; Fink, D (2010). 32nd San Antonio Breast Cancer Symposium: Highlights aus San Antonio. Leading Opinions. Medizin für die Frau, 3(2):39-40.

Betschart, C; Scheiner, D; Fink, D; Peruccini, D (2010). Overactive Bladder: Individuelles Stufenkonzept in Abklärung und Therapie. Leading Opinions. Medizin für die Frau, 3(2):18-20.

Pók, J (2010). Was lässt Frauenbrüste schmerzen? Ursachen und Differenzialdiagnose der Mastodynie. Ars Medici, (9):372-373.

Fink, D (2010). Therapie des Mammakarzinoms – Wandel von der radikalen zur qualitätskontrollierten individualisierten Therapie. Praxis, 99(7):397-398.

Abou Hadeed, May Khaled Ibrahim. Evaluation Schweizer Guidelines für die Indikation der Hysterektomie im Zusammenhang mit dem Outcome für Patientinnen. 2010, University of Zurich, Faculty of Medicine.

Dedes, J. Acquired vorinostat resistance shows partial cross-resistance to "second-generation" HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities. 2010, University of Zurich, Faculty of Medicine.

Scheiner, D; Betschart, C; Perucchini, D (2010). Altersabhängige Veränderungen des Beckenbodens bei der Frau. Therapeutische Umschau, 67(1):23-26.

Betschart, C; Scheiner, D; Fink, D (2010). Basisabklärung: Wann ist eine Urodynamik sinnvoll? : Diagnostik bei Harninkontinenz und Drangbeschwerden. Gynäkologie, (2):21-25.

Pók, J (2010). Basiswissen Medizin und Genetik. In: Pók, J; Baumann-Hölzle, R; Ritzenthaler, D; Dialog Ethik Zürich. Psychosoziale Beratung bei vorgeburtlichen Untersuchungen : Anleitung für die Beratungspraxis ergänzt mit interdisziplinärem Fachwissen. Zürich: Dialog Ethik, 39-46.

Dedes, K J; Lopez-Garcia, M A; Geyer, F C; Lambros, M B K; Savage, K; Vatcheva, R; Wilkerson, P; Wetterskog, D; Lacroix-Triki, M; Natrajan, R; Reis-Filho, J S (2010). Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study. Breast Cancer Research and Treatment, 124(3):653-666.

Blank, P R; Dedes, K J; Szucs, T D (2010). Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer: a critical and systematic review. PharmacoEconomics, 28(8):629-647.

Scheiner, D (2010). Die überaktive Blase. In: Tunn, R; Hanzal, E; Perucchini, D. Urogynäkologie in Praxis und Klinik (2. Aufl.). Berlin, DE: de Gruyter, 185-215.

Imesch, P; Samartzis, E P; Fink, D (2010). Endometriose – eine epigenetische Erkrankung? Endometriose Aktuell, (2):2-4.

Imesch, P; Fink, D (2010). Endometriose: Richtiges operatives Vorgehen bei unerfülltem Kinderwunsch. Leading Opinions. Medizin für die Frau, 3(3):10-12.

Bajka, M; Tuchschmid, S; Fink, D; Székely, G; Harders, M (2010). Establishing construct validity of a virtual-reality training simulator for hysteroscopy via a multimetric scoring system. Surgical Endoscopy, 24(1):79-88.

Probst-Hensch, N M; Steiner, J H B; Schraml, P; Varga, Z; Zürrer-Härdi, U; Storz, M; Korol, D; Fehr, M K; Fink, D; Pestalozzi, B C; Lütolf, U M; Theurillat, J P; Moch, H (2010). IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity. Clinical Cancer Research, 16(3):1025-1032.

Scheiner, D; Betschart, C; Fink, D; Perucchini, D (2010). Langzeiterfahrung mit intravesikaler Botoxinjektion : Anwendung bei therapierefraktärer idiopathischer OAB-Symptomatik. Gynäkologie, (3):2-6.

Niedermann, P A. Liposomal verpacktes Cytochrom c aktiviert den intrinsischen Apoptoseweg in Zervixkarzinomzellen. 2010, University of Zurich, Faculty of Medicine.

Höckel, M; Kahn, T; Einenkel, J; Manthey, N; Braumann, U D; Hildebrandt, G; Leo, C; Hentschel, B; Vaupel, P; Horn, L C (2010). Local spread of cervical cancer revisited: a clinical and pathological pattern analysis. Gynecologic Oncology, 117(3):401-408.

Lambros, M B; Natrajan, R; Geyer, F C; Lopez-Garcia, M A; Dedes, K J; Savage, K; Lacroix-Triki, M; Jones, R L; Lord, C J; Linardopoulos, S; Ashworth, A; Reis-Filho, J S (2010). PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study. Modern Pathology, 23(10):1334-1345.

Dedes, K J; Wetterskog, D; Mendes-Pereira, A M; Natrajan, R; Lambros, M B; Geyer, F C; Vatcheva, R; Savage, K; Mackay, A; Lord, C J; Ashworth, A; Reis-Filho, J S (2010). PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors. Science Translational Medicine, 2(53):53ra75.

Fritzsche, F R; Reineke, T; Morawietz, L; Kristiansen, G; Dietel, M; Fink, D; Rageth, C; Honegger, C; Caduff, R; Moch, H; Varga, Z (2010). Pathological processing techniques and final diagnosis of breast cancer sentinel lymph nodes. Annals of Surgical Oncology, 17(11):2892-2898.

Kind, C; Pok, J (2010). Praktische Anwendung der pränatalen und präimplantativen Diagnostik. In: Kind, C; Braga, S; Studer, A. Auswählen oder annehmen? Zürich: Chronos Verlag, 43-62.

Imesch, P; Fink, D; Fedier, A (2010). Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells. Fertility and Sterility, 94(7):2838-2842.

Peruccini, D; Betschart, C; Fink, D; Scheiner, D (2010). Schlingenoperationen bei Belastungsinkontinenz: Reicht eine einzige Schlinge für alle Indikationen? Leading Opinions. Medizin für die Frau, 3(2):22-26.

Schlatter, C (2010). Sexualmedizinische Betreuung von Risikopatientinnen. Ars Medici, (1):22-25.

Hanzal, E; Scheiner, D (2010). Therapie der Belastungsinkontinenz. In: Tunn, R; Hanzal, E; Perucchini, D. Urogynäkologie in Praxis und Klinik (2. Aufl.). Berlin, DE: de Gruyter, 161-184.

Matter-Walstra, K W; Dedes, K J; Schwenkglenks, M; Brauchli, P; Szucs, T D; Pestalozzi, B C (2010). Trastuzumab beyond progression: a cost-utility analysis. Annals of Oncology, 21(11):2161-2168.

Scheiner, D Urogynäkologie in Klinik und Praxis (2., völlig neu verf. Aufl.). Edited by: Tunn, R; Hanzal, E; Perucchini, D (2010). Berlin, DE: de Gruyter.

Betschart, C; Perucchini, D (2010). Überaktive Blase: Management in der Praxis. Gynäkologie, (2):26-28.

2009

Jacob, F; Goldstein, D R; Fink, D; Heinzelmann-Schwarz, V (2009). Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs. Biomarkers in Medicine, 3(6):743-756.

Szucs, Thomas D; Dedes, Konstantin J (2009). Is cancer prevention ever going to be profitable? In: Senn, H J; Kapp, U; Ott, F. Cancer Prevention II. Berlin: Springer, 41-47.

Reinhardt, N S. Sonographische Cavum uteri-Befunde nach medikamentösem Schwangerschaftsabbruch mit Mifegyne und ihr Einfluss auf das klinische Management. 2009, University of Zurich, Faculty of Medicine.

Bajka, M; Tuchschmid, S; Streich, M; Fink, D; Székely, G; Harders, M (2009). Evaluation of a new virtual-reality training simulator for hysteroscopy. Surgical Endoscopy, 23(9):2026-2033.

Bajka, M; Weiss, S; Kunz, J; Fischer, H; Székely, G; Niederer, P (2009). Pressure-dependent hydrometra dimensions in hysteroscopy. Surgical Endoscopy, 23(9):2102-2109.

Godstaub, E. Diagnostik von Brusterkrankungen: Feinnadelpunktion und Stanzbiopsie. 2009, University of Zurich, Faculty of Medicine.

Matzinger, B; Wolf, M; Baños, A; Fink, D; Hornung, R (2009). Optical properties, physiologic parameters and tissue composition of the human uterine cervix as a function of hormonal status. Lasers in Medical Science, 24(4):561-566.

Dedes, K J; Dedes, I; Imesch, P; von Bueren, A O; Fink, D; Fedier, A (2009). Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities. Anti-Cancer Drugs, 20(5):321-333.

Fischer, S. Diagnostische und Therapeutische Optionen beim Management von Patientinnen mit Zervixkarzinom. 2009, University of Zurich, Faculty of Medicine.

Gygax, N. Laparoskopische Sakropexie – Machbarkeit, perioperatives Outcome und Kurzzeitkomplikationen von 99 an der Frauenklinik Kantonsspital Aarau operierten Patientinnen. 2009, University of Zurich, Faculty of Medicine.

Dedes, K J; Matter-Walstra, K; Schwenkglenks, M; Pestalozzi, B C; Fink, D; Brauchli, P; Szucs, T D (2009). Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: an economic evaluation. European Journal of Cancer, 45(8):1397-1406.

Furlato, M A. Erzeugung von Histondeazetylase-Hemmer-resistenten Tumorzellen durch mehrfache Behandlung mit ansteigenden Konzentrationen von Trichostatin A. 2009, University of Zurich, Faculty of Medicine.

Müller, M K; Dedes, K J; Dindo, D; Steiner, S; Hahnloser, D; Clavien, P A (2009). Impact of clinical pathways in surgery. Langenbeck's Archives of Surgery, 394(1):31-39.

Schlatter Gentinetta, C (2009). Abklärung nach sexueller Gewalt bei Migrantinnen: Problematik, Vertrauensbildung, ärztliches Vorgehen. Gynäkologie, (5):13-15.

Langer, I; Guller, U; Berclaz, G; Koechli, O R; Moch, H; Schaer, G; Fehr, M K; Hess, T; Oertli, D; Bronz, L; Schnarwyler, B; Wight, E; Uehlinger, U; Infanger, E; Burger, D; Zuber, M (2009). Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study. Breast Cancer Research and Treatment, 113(1):129-136.

Perucchini, D; Scheiner, D; Betschart, C; Fink, D (2009). Anticholinerge Therapie der hyperaktiven Blase. Ars Medici, (3):18-23.

Bauer, M; Mazza, E; Jabareen, M; Sultan, L; Bajka, M; Lang, U; Zimmermann, R; Holzapfel, G A (2009). Assessment of the in vivo biomechanical properties of the human uterine cervix in pregnancy using the aspiration test: a feasibility study. European Journal of Obstetrics and Gynecology and Reproductive Biology, 144(Suppl ):S77-S81.

Rabaglio, M; Sun, Z; Price, K N; Castiglione-Gertsch, M; Hawle, H; Thürlimann, B; Mouridsen, H; Campone, M; Forbes, J F; Paridaens, R J; Colleoni, M; Pienkowski, T; Nogaret, J M; Láng, I; Smith, I; Gelber, R D; Goldhirsch, A; Coates, A S (2009). Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Annals of Oncology, 20(9):1489-1498.

Dedes, K J; Fink, D (2009). Clinical Presentation and Surgical Management of Invasive Lobular Carcinoma of the Breast. Breast Disease, 30:31-37.

Horn, L-C; Hentschel, B; Meinel, A; Alexander, H; Leo, C (2009). Cyclooxygenase-2 expression, Ki-67 labeling index, and perifocal neovascularization in endometriotic lesions. Annals of Diagnostic Pathology, 13(6):373-377.

Giobbie-Hurder, A; Price, K N; Gelber, R D; et al; Varga, Z; Moch, H; Caduff, R (2009). Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer. Clinical Trials, 6(3):272-287.

Schlatter Gentinetta, C (2009). Dissonanzen. Schweizerische Ärztezeitung, 90(12):498.

Fink, D; Lang, U; Kimmig, R (2009). Einsatz der Laparoskopie in der gynäkologischen Onkologie. Gynäkologisch-Geburtshilfliche Rundschau, 49(3):109-110.

Pók, J (2009). Gynäkologie im Kontext der Migration. Gynäkologie, (5):1.

Schneider-Yin, Xiaoye; Kurmanaviciene, Aida; Roth, Marion; Roos, Malgorzata; Fedier, André; Minder, Elisabeth I; Walt, Heinrich (2009). Hypericin and 5-aminolevulinic acid-induced protoporphyrin IX induce enhanced phototoxicity in human endometrial cancer cells with non-coherent white light. Photodiagnosis and Photodynamic Therapy, 6(1):12-18.

Lang, U; Fink, D; Kimmig, R (2009). Intrauterine Programmierung spezifischer Organsysteme. Gynäkologisch-geburtshilfliche Rundschau, 49(1):1.

Fehr, M K; Fink, D (2009). Karzinosarkome des Uterus, maligne Müller-Mischtumoren des Uterus, Maligne mesodermale Mischtumoren, Maligne gemischte mesenchymale Tumoren (MMMT). In: Petru, E; Jonat, W; Fink, D; Köchli, O. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag GmbH, 53-58.

Imesch, P; Dedes, K; Fink, D (2009). Laparoskopische Therapie des Korpuskarzinoms: Datenlage und Evidenz. Gynäkologisch-geburtshilfliche Rundschau, 49(3):111-116.

Mouridsen, H; Giobbie-Hurder, A; Goldhirsch, A; Thürlimann, B; Paridaens, R; Smith, I; Mauriac, L; Forbes, J F; Price, K N; Regan, M M; Gelber, R D; Coates, A S (2009). Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. New England Journal of Medicine, 361(8):766-776.

Imesch, P; Dedes, K J; Furlato, M; Fink, D; Fedier, A (2009). MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells. International Journal of Oncology, 35(3):631-640.

Fehr, M K; Fink, D (2009). Maligne epitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkoms). In: Petru, E; Jonat, W; Fink, D; Köchli, O. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag GmbH, 33-51.

Fink, D; Fehr, M K (2009). Maligne nichtepitheliale Tumoren des Ovars. In: Petru, E; Jonat, W; Fink, D; Köchli, O. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag GmbH, 133-141.

Fehr, M K; Fink, D (2009). Maligne, nichtepitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkoms). In: Petru, E; Jonat, W; Fink, D; Köchli, O. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag GmbH, 59-65.

Gabriel, N; Fink, D (2009). Management des Mammakarzinoms Nebenwirkungen der endokrinen Therapie. Leading Opinions. Medizin für die Frau, 3:26-28.

Pók, J (2009). Mastodynie: Was lässt Frauenbrüste schmerzen? Der Allgemeinarzt, (12):34-35.

Imthurn, B; Kimmig, R; Lang, U; Fink, D (2009). Neue Entwicklungen in der Fortpflanzungsmedizin. Gynäkologisch-geburtshilfliche Rundschau, 49(2):53-44.

Stahel, M C; Wolf, M; Baños, A; Hornung, R (2009). Optical properties of the breast during spontaneous and birth control pill-mediated menstrual cycles. Lasers in Medical Science, 24(6):901-907.

Praxisbuch Gynäkologische Onkologie. Edited by: Petru, E; Jonat, W; Fink, D; Köchli, O (2009). Heidelberg: Springer Medizin Verlag GmbH.

Schlatter Gentinetta, C (2009). Sexualmedizin: Betreuung von Risikopatientinnen. Der Allgemeinarzt, (16):42-45.

van Dalen, A; Favier, J; Hallensleben, E; Burges, A; Stieber, P; de Bruijn, H W A; Fink, D; Ferrero, A; McGing, P; Harlozinska, A; Kainz, C; Markowska, J; Molina, R; Sturgeon, C; Bowman, A; Einarsson, R; Goike, H (2009). Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up. European Journal of Gynaecological Oncology, 30(6):609-615.

Harter, P; Hahmann, M; Lueck, H J; Poelcher, M; Wimberger, P; Ortmann, O; Canzler, U; Richter, B; Wagner, U; Hasenburg, A; Burges, A; Loibl, S; Meier, W; Huober, J; Fink, D; Schroeder, W; Muenstedt, K; Schmalfeldt, B; Emons, G; du Bois, A (2009). Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Annals of Surgical Oncology, 16(5):1324-1330.

Niederer, P; Weiss, S; Caduff, R; Bajka, M; Szekély, G; Harders, M (2009). Uterus models for use in virtual reality hysteroscopy simulators. European Journal of Obstetrics and Gynecology and Reproductive Biology, 144, S:S90-S95.

2008

Marcollo Pini, A R. Sexuelle Zufriedenheit von Frauen mit vaginaler Aplasie nach operativer Neovagina-Bildung. 2008, University of Zurich, Faculty of Medicine.

Luft, H. Diagnostik und Therapie des Ovarialkarzinoms: Erfahrungen an der Schweizerischen Pflegerinnenschule Zürich und am Spital Zollikerberg mit 145 Patientinnen in den Jahren 1993-1999. 2008, University of Zurich, Faculty of Medicine.

Baños, A. Frequency Domain Near-Infrared Spectroscopy of The Uterine Cervix During Cervical Ripening. 2008, University of Zurich, Faculty of Medicine.

Betschart, C; Scheiner, D; Maake, C; Vich, M; Slomianka, L; Fink, D; Perucchini, D (2008). Histomorphological analysis of the urogenital diaphragm in elderly women: a cadaver study. International Urogynecology Journal, 19(11):1477-1481.

Ellensohn, V F. Kurz- und mittelfristige Ergebnisse der TVT-Implantation an der Frauenklinik des Kantonsspitals St. Gallen. 2008, University of Zurich, Faculty of Medicine.

Scheiner, D (2008). Quid novi sub sole?: Streiflichter vom 37. Treffen der International Continence Society, Rotterdam, 20.-24. August 2007. In: 37. Treffen der International Continence Society, Rotterdam, 20 August 2008 - 22 August 2008, 51-53.

Schmid, D M; Roy, S; Sulser, T; Scheiner, D (2008). Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity. BJU International, 102(Suppl ):7-10.

Brandner, S. Laparoskopische Sakropexie – prospektive Fallkontrollstudie von 90 an der Frauenklinik des Kantonsspital Aarau operierten Patientinnen. 2008, University of Zurich, Faculty of Medicine.

Szucs, T D; Largeron, N; Dedes, K J; Rafia, R; Bénard, S (2008). Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland. Current Medical Research and Opinion, 24(5):1473-1483.

Varga, Z; Rageth, C; Saurenmann, E; Honegger, C; von Orelli, S; Fehr, M; Fink, D; Seifert, Burkhardt; Moch, H; Caduff, R (2008). Use of intraoperative stereomicroscopy for preventing loss of metastases during frozen sectioning of sentinel lymph nodes in breast cancer. Histopathology, 52(5):597-604.

Viale, G; Regan, M M; Maiorano, E; Stahel, R A (2008). Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group. Journal of Clinical Oncology, 26(9):1404-1410.

Schneeberger, N. Prädiktive Faktoren des lokoregionären Rezidivs beim operablen Mammakarzinom: Eine retrospektive Studie an 582 konsekutiven Patientinnen. 2008, University of Zurich, Faculty of Medicine.

Fink, D (2008). Adjuvante Systemtherapie und Tumornachsorge beim Mammakarzinom: State of the Art 2007. In: Redaelli, C. IZS Jahrbuch 2007. Zürich: Interdisziplinäres Zürcher Symposium, 49-61.

Dedes, K J; Gabriel, N; Fink, D (2008). Aktuelle adjuvante endokrine Therapie des Mammakarzinoms. Gynäkologisch-geburtshilfliche Rundschau, 48(3):130-137.

Fink, D; Schmalenfeldt, B; du Bois, A; Burges, A; Emons, G; Gropp, M; Harter, P; Hasenburg, A; Hauptmann, S; Jäger, W; Kimmig, R; Kommoss, F; Kreienberg, R; Kuhn, W; Meier, W; Münstedt, K; Ortmann, O; Pfisterer, J; Richter, B; Runnebaum, I; Schröder, W; Sehouli, J; Tanner, B; Wagner, U (2008). Aktuelle und zukünftige Entwicklungen in der Diagnostik und Therapie des Ovarialkarzinoms. Geburtshilfe und Frauenheilkunde, 68(4):382-388.

Perucchini, D; Scheiner, D; Betschart, C; Fink, D (2008). Anticholinerge Therapie der hyperaktiven Blase: Wie wird optimiert? Gynäkologie, (5):23-28.

Szucs, T D; Dedes, K J (2008). Balancing costs and benefits in cancer therapy and prevention. Annals of Oncology, 19(Suppl.):vii313-vii319.

Mazza, E; Grau, P; Hollenstein, M; Bajka, M (2008). Constitutive modeling of human liver based on in vivo measurements. In: Metaxas, D. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2008. Berlin / Heidelberg: Springer, 726-733.

Sinha, C; Köhler, H; Fink, D (2008). Continuous Medical Education. Praxis, 97(25):1321-1328; quiz 1329-1330.

Imesch, P; Fink, D (2008). Das Endometriumkarzinom: Epidemiologie, Präkanzerosen, Diagnostik, Therapie und Nachsorge. Schweizer Zeitschrift für Onkologie, (5):6-10.

Schmidt, A M; Fink, D (2008). Das Ovarialkarzinom: Aktuelle Therapiestrategien im frühen und fortgeschrittenen Stadium. Schweizer Zeitschrift für Onkologie, (5):12-14.

Scheiner, D; Betschart, C; Zachmann, S; Fink, D; Perucchini, D (2008). Das Urethralsyndrom: Prävalenz, Differenzialdiagnose,Therapie. Gynäkologie, (2):14-16.

Pók, J (2008). Designer Babys? Bioethica Forum, 1(2):104-105.

Schlatter Gentinetta, C (2008). Die Nachsorge bei gynäkologischen Tumoren: Empfehlungen nach der Primärtherapie bei typischen Beschwerden und Risiken. Schweizer Zeitschrift für Onkologie, (5):21-25.

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Barghorn, A; Saller, E; Frei, C; Storz, M; Behnke, S; Seifert, Burkhardt; Fehr, M; Fink, D; Rageth, C; Linsenmeier, C; Pestalozzi, B; Chen, Y T; Knuth, A; Jäger, D; Moch, H (2008). Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. International Journal of Cancer, 122(7):1585-1591.

Lang, U; Fink, D; Kimmig, R (2008). Fetale Programmierung = Fetal programming. Gynäkologisch-Geburtshilfliche Rundschau, 48(4):205-206.

Fink, D (2008). Ideal in der Praxis: die gynäkologisch-onkologische Nachsorge. Schweizer Zeitschrift für Onkologie, (5):1.

Viereck, V; Eberhard, J (2008). Inkontinenzoperationen - Indikationen, Auswahl der Operationsmethode, Operationstechnik, Umgang mit Früh- und Spätkomplikationen. Journal für Urologie und Urogynäkologie, 15(3):37-42.

Weiss, S; Niederer, P; Navarini, A; Caduff, R; Bajka, M (2008). Inverse finite element characterization of the human myometrium derived from uniaxial compression experiments. Biomedizinische Technik. Biomedical Engineering, 53(2):52-58.

Betschart, C; Scheiner, D; Fink, D; Perucchini, D (2008). Konservative Therapie von Harninkontinenz, Drangsymptomen und Genitaldeszensus. Journal für Urologie und Urogynäkologie, 15(3):23-30.

Kimmig, R; Fink, D; Lang, U (2008). Körperliche Integrität versus onkologische Sicherheit: Synthese wichtiger Aspekte in der Therapie des Mammakarzinoms. Gynäkologisch-geburtshilfliche Rundschau, 48(2):55.

Tuchschmid, S; Bajka, M; Szczerba, D; Lloyd, B A; Székely, G; Harders, M (2008). Modeling intravasation of liquid distension media in surgical simulators. Medical Image Analysis, 12(5):567-576.

Scheiner, D; Betschart, C; Zachmann, S; Fink, D; Perucchini, D (2008). Moderne Schlingentechniken bei Belastungsinkontinenz: Technik, Studienresultate, Komplikationen, Differenzialindikation. Gynäkologie, (2):17-22.

Gabriel, N (2008). Nebenwirkungen der endokrinen Therapie beim Mammakarzinom: Erkennen, Vorsorgen und Behandeln. Schweizer Zeitschrift für Onkologie, (5):16-20.

Dedes, K J; Beneder, C; Samartzis, N; Muller, M D; Fink, D; Fehr, M K (2008). Outcome of treated anogenital intraepithelial neoplasia among human immunodeficiency virus-infected women. Journal of Reproductive Medicine, 53(12):947-951.

Overactive Bladder - Fragen und Antworten. Edited by: Perucchini, D (2008). Bremen: UNI-MED Verlag AG.

Petignat, P; Stucki, D; Altermatt, H J; Seydoux, J; Jacob, S; Brioschi, P A; Fink, D; Fehr, M; Delaloye, J F; Loubeyre, P; Hohl, M; Mueller, M; Dubuisson, J B (2008). Place de la laparoscopie dans le traitement du cancer de l'endomètre. Revue Médicale Suisse, 4(153):995-998.

Viale, G; Giobbie-Hurder, A; Regan, M M; Stahel, R A (2008). Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. Journal of Clinical Oncology, 26(34):5569-5575.

Pók, J (2008). Pränatale Diagnostik im Spitalalltag. In: Hürlimann, D C; Baumann-Hölzle, R; Müller, H. Der Beratungsprozess in der Pränatalen Diagnostik. Bern: Peter Lang AG, 165-172.

Fedier, A. Strategies for prevention, circumvention, and reversal of drug resistance in tumor cells. 2008, University of Zurich, Faculty of Medicine.

Kociszewski, J; Rautenberg, O; Perucchini, D; Eberhard, J; Geissbühler, V; Hilgers, R; Viereck, V (2008). Tape functionality: sonographic tape characteristics and outcome after TVT incontinence surgery. Neurourology and Urodynamics, 27(6):485-490.

O'Brien, P M; Davies, M J; Scurry, J P; Smith, A N; Barton, C A; Henderson, M J; Saunders, D N; Gloss, B S; Patterson, K I; Clancy, J L; Heinzelmann-Schwarz, V A; Murali, R; Scolyer, R A; Zeng, Y; Williams, E D; Scurr, L; Defazio, A; Quinn, D I; Watts, C K W; Hacker, N F; Henshall, S M; Sutherland, R L (2008). The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. British Journal of Cancer, 98(6):1085-1093.

Blochlinger-Wegmann, B; Werner, M; Scheiner, D; Fink, D; Perucchini, D (2008). Urethraldivertikel als Ursache chronischer urogenitaler Schmerzen: Ein Fallbericht. Gynäkologisch-Geburtshilfliche Rundschau, 48(1):35-37.

Eberhard, J (2008). Urogenitale Beschwerden - Häufige Frauenleiden. Journal für Urologie und Urogynäkologie, 15(3):4-5.

Fink, D; Lang, U; Kimmig, R (2008). Wichtige Fortschritte in der adjuvanten Systemtherapie des Mammakarzinoms. Gynäkologisch-geburtshilfliche Rundschau, 48(3):111-112.

Ravaioli, A; Monti, F; Regan, M M; Maffini, F; Mastropasqua, M G; Spataro, V; Castiglione-Gertsch, M; Panzini, I; Gianni, L; Goldhirsch, A; Coates, A; Price, K N; Gusterson, B A; Viale, G (2008). p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Annals of Oncology, 19(4):660-668.

2004

Degen Iseli, Andrea Franziska; Gabrecht, Tanja; Mosimann, Laurent; Fehr, Mathias K; Hornung, René; Schwarz, Viola A; Tadir, Yona; Steiner, Rolf A; Wagnières, Georges; Wyss, Pius (2004). Photodynamic endometrial ablation for the treatment of dysfunctional uterine bleeding: a preliminary report. Lasers in surgery and medicine, 34(1):1-4.

2003

Wyss, Pius; Degen Iseli, Andrea Franziska; Caduff, Rosmarie; Hornung, Rene; Haller, Urs; Fehr, Mathias (2003). Fluorescence hysteroscopy using 5-aminolevulinic: a descriptive study. Lasers in surgery and medicine, 33(3):209-212.

Wyss, Pius; Caduff, Rosmarie; Tadir, Yona; Degen Iseli, Andrea Franziska; Wagnières, Georges; Schwarz, Viola; Haller, Urs; Fehr, Mathias (2003). Photodynamic endometrial ablation: morphological study. Lasers in surgery and medicine, 32(4):305-309.

2002

Fehr, Mathias K; Hornung, René; Degen Iseli, Andrea Franziska; Schwarz, Viola A; Fink, Daniel; Haller, Urs; Wyss, Pius (2002). Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Lasers in surgery and medicine, 30(4):273-279.

This list was generated on Fri Jul 28 01:05:33 2017 CEST.